{
  "CellLine_hpscreg_id": "LEIi009-A",
  "CellLine_alt_names": [
    "1374ips1"
  ],
  "CellLine_cell_line_type": "hiPSC",
  "CellLine_source_cell_type": "Dermal fibroblasts",
  "CellLine_publication_doi": "10.1016/j.scr.2018.11.018",
  "CellLine_publication_pmid": "",
  "CellLine_publication_title": "Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier",
  "CellLine_publication_first_author": "Samuel McLenachan",
  "CellLine_publication_last_author": "Fred K. Chen",
  "CellLine_publication_journal": "Stem Cell Research",
  "CellLine_publication_year": 2019,
  "CellLine_donor_age": 54,
  "CellLine_donor_sex": "Female",
  "CellLine_donor_disease_name": "Retinitis Pigmentosa 11",
  "CellLine_donor_disease_description": "Non-penetrant carrier of the PRPF31 mutation with no retinal disease.",
  "CellLine_source_tissue": "Skin",
  "CellLine_source": "donor",
  "CellLine_contact_name": "Fred Chen",
  "CellLine_contact_email": "fredchen@lei.org.au",
  "CellLine_contact_phone": "",
  "CellLine_maintainer": "Lions Eye Institute, Nedlands, Western Australia, Australia",
  "CellLine_producer": "Lions Eye Institute, Nedlands, Western Australia, Australia",
  "CellLine_frozen": true,
  "GenomicAlteration_performed": true,
  "GenomicAlteration_mutation_type": "variant",
  "GenomicAlteration_cytoband": "19q13.42",
  "GenomicAlteration_delivery_method": "",
  "GenomicAlteration_loci_name": "PRPF31",
  "GenomicAlteration_loci_chromosome": "19",
  "GenomicAlteration_loci_start": 0,
  "GenomicAlteration_loci_end": 0,
  "GenomicAlteration_loci_group": "",
  "GenomicAlteration_loci_disease": "Retinitis Pigmentosa 11",
  "GenomicAlteration_description": "Dominant nonsense mutation in the PRPF31 gene (NM_015629.3:c.1205C > A p.(Ser402Ter))",
  "GenomicAlteration_genotype": "Heterozygous",
  "PluripotencyCharacterisation_cell_type": "Ectoderm",
  "PluripotencyCharacterisation_shown_potency": true,
  "PluripotencyCharacterisation_marker_list": [
    "OCT4",
    "NANOG",
    "SOX2",
    "TRA-1-81"
  ],
  "PluripotencyCharacterisation_method": "Immunocytochemistry and RT-qPCR",
  "PluripotencyCharacterisation_differentiation_profile": "in vitro spontaneous differentiation",
  "ReprogrammingMethod_vector_type": "non-integrated",
  "ReprogrammingMethod_vector_name": "Episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, shRNA for p53 and mir302/367 microRNA",
  "ReprogrammingMethod_kit": "Episomal iPSC Reprogramming Plasmid kit (SC900A-1, System Biosciences)",
  "ReprogrammingMethod_detected": true,
  "GenomicCharacterisation_passage_number": 10,
  "GenomicCharacterisation_karyotype": "46, XX",
  "GenomicCharacterisation_karyotype_method": "Molecular Kartotyping by SNP array",
  "GenomicCharacterisation_summary": "Digital karyotyping by genome-wide SNP profiling and copy number variation analysis demonstrated a normal karyotype.",
  "STR_Results_exists": true,
  "STR_Results_loci": 16,
  "STR_Results_group": "Non-HLA",
  "STR_Results_allele_1": "",
  "STR_Results_allele_2": "",
  "InducedDerivation_i_source_cell_type": "Dermal fibroblasts",
  "InducedDerivation_i_cell_origin": "Skin",
  "InducedDerivation_derivation_year": "2017",
  "InducedDerivation_vector_type": "non-integrated",
  "InducedDerivation_vector_name": "Episomal plasmids",
  "InducedDerivation_kit_name": "Episomal iPSC Reprogramming Plasmid kit (SC900A-1, System Biosciences)",
  "Ethics": [
    {
      "ethics_number": "RA/4/1/7916",
      "approval_date": "",
      "institutional_HREC": "Human Research Ethics Office, University of Western Australia"
    }
  ],
  "MicrobiologyVirologyScreening_performed": true,
  "MicrobiologyVirologyScreening_hiv1": "",
  "MicrobiologyVirologyScreening_hiv2": "",
  "MicrobiologyVirologyScreening_hep_b": "",
  "MicrobiologyVirologyScreening_hep_c": "",
  "MicrobiologyVirologyScreening_mycoplasma": "Negative",
  "MicrobiologyVirologyScreening_other": "",
  "MicrobiologyVirologyScreening_other_result": "",
  "CultureMedium_co2_concentration": 5,
  "CultureMedium_o2_concentration": 21,
  "CultureMedium_rho_kinase_sed": "",
  "CultureMedium_passage_method": "Mechanically",
  "CultureMedium_other_passage_method": "",
  "CultureMedium_methods_io_id": "",
  "CultureMedium_base_medium": "TeSR-E8 medium",
  "CultureMedium_base_coat": "Geltrex-coated",
  "CultureMedium_MediumComponents_medium_component_name": "",
  "CultureMedium_MediumComponents_company": "StemCell Technologies",
  "CultureMedium_MediumComponents_component_type": ""
}